What if Type 2 Diabetes patients didn't require insulin injections?
Intarcia Therapeutics is eliminating injections all together...
What if you could try a Tattoo before you get inked?
InkHunter lets you try before you make it permanent...
What if Wall Street stopped using paper?
Symbiont is bridging the gap between the emerging blockchain ecosystem and Wall Street...
Smart Securities®, Intelligent Markets
Recent News
Symbiont, the market-leading smart contracts platform for institutional applications of distributed ledger technology, today announced a strategic partnership with Chinese software giant Hundsun Technologies Inc, which includes an investment by a division of Hundsun in Symbiont’s Series A-1 round. The investment is Hundsun’s first in both the United States and in distributed ledger technology. Symbiont’s board of directors...
In the future, it may be possible to prevent HIV through the help of a miniature pump that’s been implanted underneath one’s skin. That’s the promise of the pharmaceutical company Intarcia Therapeutics, whose chairman and president Kurt Graves spoke at Fortune’s Brainstorm Health conference Tuesday in San Diego. Intarcia is currently developing an HIV-preventing drug and treatment technology that Graves hopes could eventually solve a big problem facing the health care industry and the treatment of chronic diseases
Announcements
Team
STEPHEN GARROW
Managing Partner - New York
DAVID VOGEL
Managing Partner - Boston
TIM MITROVICH
Partner - New York
Featured Portfolio Companies
